Email Updates

You are here

Home

Bangkok Tenofovir Study (BTS) Follow-Up

Status
Completed
Phase
Open Label
Objective

Follow-on trial of daily oral TDF in men and women who inject drugs.

*Preliminary data reported in February 2015 showed that 35% of eligible participants decided to participate in the OLE, with a limited number of participants returning to the clinic suggesting the need for adherence support.*
Prevention Option(s)
PrEP
Study Design
Open label
Results
Enrollment and preliminary follow-up of injecting drug users receiving pre-exposure prophylaxis in Bangkok
Official Code
Bangkok Tenofovir Open Label follow-up Study
Trial Sponsors
Bangkok Metropolitan Administration, CDC, Gilead
Population
Women
Men
Injecting drug users
Sites

Site(s) - Bangkok

Bangkok
Thailand